These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28945248)

  • 1. Atomic view of the energy landscape in the allosteric regulation of Abl kinase.
    Saleh T; Rossi P; Kalodimos CG
    Nat Struct Mol Biol; 2017 Nov; 24(11):893-901. PubMed ID: 28945248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atomistic Modeling of the ABL Kinase Regulation by Allosteric Modulators Using Structural Perturbation Analysis and Community-Based Network Reconstruction of Allosteric Communications.
    Astl L; Verkhivker GM
    J Chem Theory Comput; 2019 May; 15(5):3362-3380. PubMed ID: 31017783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Dynamics Simulations and Structural Network Analysis of c-Abl and c-Src Kinase Core Proteins: Capturing Allosteric Mechanisms and Communication Pathways from Residue Centrality.
    Tse A; Verkhivker GM
    J Chem Inf Model; 2015 Aug; 55(8):1645-62. PubMed ID: 26236953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational modeling of allosteric communication reveals organizing principles of mutation-induced signaling in ABL and EGFR kinases.
    Dixit A; Verkhivker GM
    PLoS Comput Biol; 2011 Oct; 7(10):e1002179. PubMed ID: 21998569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding or bending: distinction of allosteric Abl kinase agonists from antagonists by an NMR-based conformational assay.
    Jahnke W; Grotzfeld RM; Pellé X; Strauss A; Fendrich G; Cowan-Jacob SW; Cotesta S; Fabbro D; Furet P; Mestan J; Marzinzik AL
    J Am Chem Soc; 2010 May; 132(20):7043-8. PubMed ID: 20450175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the allosteric inhibition of Abl kinase.
    Fallacara AL; Tintori C; Radi M; Schenone S; Botta M
    J Chem Inf Model; 2014 May; 54(5):1325-38. PubMed ID: 24787133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence Polarization Screening Assays for Small Molecule Allosteric Modulators of ABL Kinase Function.
    Grover P; Shi H; Baumgartner M; Camacho CJ; Smithgall TE
    PLoS One; 2015; 10(7):e0133590. PubMed ID: 26222440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Mutation-Induced Allosteric Changes in Structures and Conformational Ensembles of the ABL Kinase Using AlphaFold2 Adaptations with Alanine Sequence Scanning.
    Raisinghani N; Alshahrani M; Gupta G; Verkhivker G
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-world networks of residue interactions in the Abl kinase complexes with cancer drugs: topology of allosteric communication pathways can determine drug resistance effects.
    Tse A; Verkhivker GM
    Mol Biosyst; 2015 Jul; 11(7):2082-95. PubMed ID: 25996455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and characterization of a cell-permeable, small-molecule c-Abl kinase activator that binds to the myristoyl binding site.
    Yang J; Campobasso N; Biju MP; Fisher K; Pan XQ; Cottom J; Galbraith S; Ho T; Zhang H; Hong X; Ward P; Hofmann G; Siegfried B; Zappacosta F; Washio Y; Cao P; Qu J; Bertrand S; Wang DY; Head MS; Li H; Moores S; Lai Z; Johanson K; Burton G; Erickson-Miller C; Simpson G; Tummino P; Copeland RA; Oliff A
    Chem Biol; 2011 Feb; 18(2):177-86. PubMed ID: 21338916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HRD Motif as the Central Hub of the Signaling Network for Activation Loop Autophosphorylation in Abl Kinase.
    La Sala G; Riccardi L; Gaspari R; Cavalli A; Hantschel O; De Vivo M
    J Chem Theory Comput; 2016 Nov; 12(11):5563-5574. PubMed ID: 27682200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The high-resolution NMR structure of the R21A Spc-SH3:P41 complex: understanding the determinants of binding affinity by comparison with Abl-SH3.
    Casares S; Ab E; Eshuis H; Lopez-Mayorga O; van Nuland NA; Conejero-Lara F
    BMC Struct Biol; 2007 Apr; 7():22. PubMed ID: 17407569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of a Randomized Sequence Scanning Approach in AlphaFold2 and Local Frustration Profiling of Conformational States Enable Interpretable Atomistic Characterization of Conformational Ensembles and Detection of Hidden Allosteric States in the ABL1 Protein Kinase.
    Raisinghani N; Alshahrani M; Gupta G; Tian H; Xiao S; Tao P; Verkhivker GM
    J Chem Theory Comput; 2024 Jun; 20(12):5317-5336. PubMed ID: 38865109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hierarchical modeling of activation mechanisms in the ABL and EGFR kinase domains: thermodynamic and mechanistic catalysts of kinase activation by cancer mutations.
    Dixit A; Verkhivker GM
    PLoS Comput Biol; 2009 Aug; 5(8):e1000487. PubMed ID: 19714203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the c-Abl and Bcr-Abl tyrosine kinases.
    Hantschel O; Superti-Furga G
    Nat Rev Mol Cell Biol; 2004 Jan; 5(1):33-44. PubMed ID: 14708008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Abl SH2-kinase linker naturally adopts a conformation competent for SH3 domain binding.
    Chen S; Brier S; Smithgall TE; Engen JR
    Protein Sci; 2007 Apr; 16(4):572-81. PubMed ID: 17327393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of the Abl kinase directed at either the ATP- or myristate-binding site.
    Fabbro D; Manley PW; Jahnke W; Liebetanz J; Szyttenholm A; Fendrich G; Strauss A; Zhang J; Gray NS; Adrian F; Warmuth M; Pelle X; Grotzfeld R; Berst F; Marzinzik A; Cowan-Jacob SW; Furet P; Mestan J
    Biochim Biophys Acta; 2010 Mar; 1804(3):454-62. PubMed ID: 20152788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling of the ABL and ARG proteins predicts two functionally critical regions that are natively unfolded.
    Buffa P; Manzella L; Consoli ML; Messina A; Vigneri P
    Proteins; 2007 Apr; 67(1):1-11. PubMed ID: 17211892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase.
    Dorey K; Engen JR; Kretzschmar J; Wilm M; Neubauer G; Schindler T; Superti-Furga G
    Oncogene; 2001 Dec; 20(56):8075-84. PubMed ID: 11781820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.